One cross-sectional study indicated that, after adjusting for covariates including demographic characteristics, lipid-lowering drugs, and hypoglycemic agents, increased glucagon levels were independently associated with an increased risk of diabetic kidney disease (11). This evidence concerns the gene GCG and diabetic kidney disease.